PL1957452T3 - "Nowe postacie soli magnezowej kwasu [R-(R*,R*)]-2-(4-fluorofenylo)-ß,δ-dihydroksy-5-(1-metyloetylo)-3-fenylo-4-[(fenylamino)karbonylo]-1H-pirolo-1-heptanowego" - Google Patents

"Nowe postacie soli magnezowej kwasu [R-(R*,R*)]-2-(4-fluorofenylo)-ß,δ-dihydroksy-5-(1-metyloetylo)-3-fenylo-4-[(fenylamino)karbonylo]-1H-pirolo-1-heptanowego"

Info

Publication number
PL1957452T3
PL1957452T3 PL06809231T PL06809231T PL1957452T3 PL 1957452 T3 PL1957452 T3 PL 1957452T3 PL 06809231 T PL06809231 T PL 06809231T PL 06809231 T PL06809231 T PL 06809231T PL 1957452 T3 PL1957452 T3 PL 1957452T3
Authority
PL
Poland
Prior art keywords
hept
phenylamino
methylethyl
fluorophenyl
pyrrole
Prior art date
Application number
PL06809231T
Other languages
English (en)
Inventor
Jason Albert Leonard
Jonathan Mark Miller
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42664732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1957452(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority claimed from PCT/IB2006/003239 external-priority patent/WO2007057755A1/en
Publication of PL1957452T3 publication Critical patent/PL1957452T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
PL06809231T 2005-11-21 2006-11-09 "Nowe postacie soli magnezowej kwasu [R-(R*,R*)]-2-(4-fluorofenylo)-ß,δ-dihydroksy-5-(1-metyloetylo)-3-fenylo-4-[(fenylamino)karbonylo]-1H-pirolo-1-heptanowego" PL1957452T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73844705P 2005-11-21 2005-11-21
EP06809231A EP1957452B1 (en) 2005-11-21 2006-11-09 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium
PCT/IB2006/003239 WO2007057755A1 (en) 2005-11-21 2006-11-09 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium

Publications (1)

Publication Number Publication Date
PL1957452T3 true PL1957452T3 (pl) 2010-09-30

Family

ID=42664732

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06809231T PL1957452T3 (pl) 2005-11-21 2006-11-09 "Nowe postacie soli magnezowej kwasu [R-(R*,R*)]-2-(4-fluorofenylo)-ß,δ-dihydroksy-5-(1-metyloetylo)-3-fenylo-4-[(fenylamino)karbonylo]-1H-pirolo-1-heptanowego"

Country Status (3)

Country Link
EP (1) EP1957452B1 (pl)
PL (1) PL1957452T3 (pl)
SI (1) SI1957452T1 (pl)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi

Also Published As

Publication number Publication date
SI1957452T1 (sl) 2010-08-31
EP1957452B1 (en) 2010-05-05
EP1957452A1 (en) 2008-08-20

Similar Documents

Publication Publication Date Title
WO2004027075A3 (en) Chemoenzymatic methods for the synthesis of statins and stain intermediates
TWI319396B (en) Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1)
IL191287A0 (en) Atorvastatin formulation
IL191203A0 (en) Pharmaceutical combination comprising atorvastatin derivatives
BR0116785A (pt) Processo para a sìntese da forma v de atorvastatina e fenilboronatos como compostos intermediários
IL187331A0 (en) Terminal sterilization of injectable collagen products
MXPA04000889A (es) Formas cristalinas vi y vii de atorvastatina calcica.
HUP0402590A3 (en) Method of manufacturing an amorphous form of the hemi-calcium salt of (3r,5r)7-3-phenyl-4-phenylcarbomoyl-2-(4-fluorophenyl)-5-isopropyl-pyrrol-1-yl!-3, 5-dihydroxyheptanoic acid (atorvastatin)
IL186465A0 (en) Process for preparing levetiracetam and racemization of (r)-and(s)-2-amino butynamide and the corresponding acid derivatives
EP1472220A4 (en) CALCIUM SALT CRYSTALLINE (2: 1) ACID (R- (R *, R *)) - 2- (4-FLUOROPHENYL) -BETA, DELTA-DIHYDROXY-5- (1-METHYLETHYL) -3-PHENYL -4 - ((phenylamino) CARBONYL) -1H-Pyrrole-heptanoic
ZA200508204B (en) Pharmaceutical composition of atorvastatin
IL180708A0 (en) Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation
IL187886A0 (en) Crystal form of atorvastatin hemi -calcium and processes for preparation thereof
EP1963263A4 (en) POLYMORPHS OF A MAGNESIUM SALT (2: 1) OF ACID [R- (R *, R *)] - 2- (4-FLUOROPHENYL) -BETA, DELTA-DIHYDROXY-5- (L-METHYLETHYL) - 3-PHENYL-4 - [(phenylamino) carbonyl] -LH-PYRROLE-L-heptanoic
DK1957452T3 (da) Nye former af [R-(R*,R*)]-2-(4-fluorphenyl)-B,B-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-heptansyre- magnesium
WO2008002655A3 (en) Crystalline forms of atorvastatin
IL186499A (en) Processes for the preparation of a crystalline form of atorostatin mycelium
IL173651A0 (en) Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
EP1986997A4 (en) NEW CRYSTALLINE HEMI-CALCIUM FORM OF ATORVASTATIN
PL1957452T3 (pl) "Nowe postacie soli magnezowej kwasu [R-(R*,R*)]-2-(4-fluorofenylo)-ß,δ-dihydroksy-5-(1-metyloetylo)-3-fenylo-4-[(fenylamino)karbonylo]-1H-pirolo-1-heptanowego"
EP1853559A4 (en) IMPROVED PROCESS FOR THE PREPARATION OF ATORVASTATIN AND INTERMEDIATES THEREOF
IL173012A0 (en) Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin
EP1853558A4 (en) PROCESS FOR THE PRODUCTION OF ATORVASTATIN HEMICALCIUM
EP1871396A4 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS WITH AN HMG COA REDUCTASE INHIBITOR
AU2003278597A1 (en) (r-(r*,r*))-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-((1-methylethyl) -3-phenyl-4-((phenylamino) carbonyl)- 1h-pyrrole-1-heptanoic acid iron salt